Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Minot Light Capital Partners. This analysis is provided for institutional research purposes only and is not investment advice.
"Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutional forced liquidations into high-conviction buying opportunities."
Minot Light Capital Partners reports a net return of 14.4% (19.2% gross) for 2025, outperforming the S&P 500 and Russell 2000 but slightly lagging the micro-cap IWC index. The letter outlines critical lessons from their first full year: 1) embracing increased volatility to buy out-of-favor names; 2) identifying and eliminating 'unforced errors' (such as holding leveraged balance sheets or bad corporate governance); 3) upgrading downside support metrics to favor tangible balance-sheet items over historical multiples; and 4) avoiding 'errors of omission' by aggressively scaling up position sizes in emerging growth companies that hit operational milestones. The managers report a strong start to 2026 with a reversal of late-2025 losses, particularly highlighted by Outset Medical (OM) rebounding.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Growth Outlook
Market outlook remains high conviction: Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Risk Appetite
Risk appetite posture is above average conviction: Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Forward Guidance
Forward guidance signal: Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Language Signal
Tone analysis indicates above average conviction language: Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
Time Horizon
Investment time horizon reflects a high conviction orientation. Minot Light delivered a strong 14.4% net return in its first full year (2025), and is actively refining its underwriting process to turn extreme micro-cap volatility and institutio...
